Arthritis, Psoriatic (PsA)NCT07865390
Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
A study testing Patient-Reported Outcomes Dashboard With Goal Setting in people with Arthritis, Psoriatic (PsA) and Arthritis, Rheumatoid (RA), run by Northwestern University at 1 site in United States.
Trial summary
The goal of this clinical trial is to learn whether showing patient-reported symptoms and personal treatment goals to rheumatology clinicians on a dashboard in the electronic health record improves shared decision-making for adults with rheumatoid arthritis or psoriatic arthritis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA)
- What is being tested?
- Patient-Reported Outcomes Dashboard With Goal Setting
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2027to 29 Feb 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18 years or older
- Diagnosis of rheumatoid arthritis or psoriatic arthritis
- Receiving care at a Northwestern Medicine rheumatology clinic, with an upcoming rheumatology visit
- Active patient portal (MyChart) account
- Able to read and complete questionnaires in English
- Able to provide informed consent
Who cannot join
- Unable to provide informed consent
- Unable to complete study questionnaires in English
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Northwestern Medicine Rheumatology
Chicago, Illinois, 60611
Maja Kuharic, Msc, Mpharm, PHD, 9045547009, maja.kuharic@northwestern.edu
About this study
Official title: Personalizing Inflammatory Arthritis Rheumatology Care: Integrating PROMIS Measures and Patient Preferences to Improve Shared Decision-Making
The goal of this clinical trial is to learn whether showing patient-reported symptoms and personal treatment goals to rheumatology clinicians on a dashboard in the electronic health record improves shared decision-making for adults with rheumatoid arthritis or psoriatic arthritis.
The main questions it aims to answer are:
Read more
- Do patients whose clinicians use the dashboard report more shared decision-making during their rheumatology visits than patients who receive usual care?
- Do patients in the dashboard group report greater progress toward their personal goals and more confidence in managing their symptoms after 6 months?
Researchers will compare the dashboard group to a usual care group to see if the dashboard improves shared decision-making, goal attainment, and self-efficacy.
Participants will:
- Complete a routine symptom questionnaire before their rheumatology visits, as all clinic patients do
- Choose personal treatment goals and rate their progress toward those goals 6 months later
- Complete short surveys before and after two rheumatology visits about 6 months apart
Participants in the dashboard group will also complete questionnaires in the patient portal about pain, fatigue, physical function, sleep, and morning stiffness before each visit. Their answers and goals will be shown to their clinician on a dashboard to guide the conversation during the visit.
- Being tested
- Patient-Reported Outcomes Dashboard With Goal Setting
- Keywords
- Patient Reported Outcome Measures, Shared Decision Making, PROMIS, Goal Attainment Scaling, Electronic Health Records, Clinical Dashboard, Rheumatology
- Medical subject headings
- Arthritis, Psoriatic, Arthritis, Rheumatoid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patient-Reported Outcomes Dashboard With Goal SettingOther
A clinician-facing dashboard embedded in the Epic electronic health record that displays the participant's PROMIS computer adaptive test (CAT) scores (PROMIS Pain Interference, PROMIS Fatigue, PROMIS Physical Function, PROMIS Sleep Disturbance), morning stiffness, and self-selected treatment goals collected through the patient portal before the visit. Clinicians receive training on using the dashboard to support shared decision-making and goal-directed care during the visit.
| Study group | Role | What they receive |
|---|---|---|
| PRO Dashboard With Goal Setting | Experimental | Before each of two routine rheumatology visits approximately 6 months apart, participants complete the RAPID3 (standard of care for all clinic patients) plus an additional questionnaire series in the patient portal: selection of personal treatment goals, a morning stiffness question, and four PROMIS computer adaptive tests (Pain Interference, Fatigue, Physical Function, and Sleep Disturbance). Responses and goals are displayed to the treating clinician on a dashboard in the electronic health record for use during the visit. Receives: Other: Patient-Reported Outcomes Dashboard With Goal Setting |
| Usual Care | No intervention | Participants receive usual rheumatology care. They do not receive the additional questionnaire series, and no study dashboard is displayed to the clinician. For outcome assessment only, participants select personal goals and rate goal attainment in study surveys that are not shared with the clinician. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Shared Decision-Making
CollaboRATE is a 3-item patient-reported measure of shared decision-making during a clinical encounter. Each item is rated from 0 (no effort was made) to 9 (every effort was made). The score is the mean of the three items (range 0 to 9); higher scores indicate more shared decision-making.
Measured: Within 48 hours after the second study visit (approximately 6 months after enrollment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study start1 Jan 2027 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion29 Feb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arthritis, Psoriatic (PsA)Studies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two-arm parallel randomized trial at a single academic rheumatology practice. Patients are randomized individually to the dashboard intervention or usual care and followed across two routine rheumatology visits approximately 6 months apart. The same clinicians see patients in both arms.
- Masking
- None (open label)
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maja Kuharic, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07865390
- Sponsor's protocol ID
- STU00226297
- Other IDs
- AWD00003792
- Status last verified
- Oct 2026
- First submitted
- 3 Oct 2026
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided